Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Grants for Enhanced Surveillance for New Vaccine Preventable Diseases Biosecurity November 30, 2015 …
Protein Sciences Awarded DoD Grant for Novel Adenovirus Vaccine Contracts + Grants November 13, 2015 …
